September 1, 2020
Fujifilm Toyama Chemical said on August 31 that it has filed its new radiopharmaceutical compound F-1515 (lutetium ( 177 Lu) oxodotreotide) in Japan for the treatment of pancreatic, gastrointestinal, and pulmonary neuroendocrine tumors. F-1515 is a somatostatin analog labeled with...read more